Preventive ceftriaxone in patients at high risk of stroke-associated pneumonia. A post-hoc analysis of the PASS trial.

Wouter M Sluis,Willeke F Westendorp,Diederik van de Beek,Paul J Nederkoorn,H Bart van der Worp

PloS one（2022）

引用 1|浏览1

暂无评分

摘要

This post-hoc analysis of PASS confirmed higher rates of pneumonia with higher ISAN scores, and suggests that in acute stroke patients with an ISAN score of ≥15, preventive ceftriaxone for four days may reduce pneumonia rate.

查看译文

关键词

preventive ceftriaxone,pneumonia,stroke-associated,post-hoc

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要